perphenazine has been researched along with physostigmine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Antaki, AJ; Rollin, P | 1 |
Färber, G; Fraling, F; Herz, A; Niedner, I | 1 |
Heiser, JF; Wilbert, DE | 1 |
Davis, JM; el-Yosef, MK; Janowsky, DS; Sekerke, HJ | 1 |
Bhargava, LP; Dandiya, PC | 1 |
2 review(s) available for perphenazine and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Poisoning due to tricyclic antidepressants in children and adolescents].
Topics: Adolescent; Amitriptyline; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Central Nervous System Diseases; Diazepam; Female; Gastric Lavage; Humans; Infant; Male; Perphenazine; Physostigmine; Psychoses, Substance-Induced | 1979 |
8 other study(ies) available for perphenazine and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacologically induced alterations of cortical and subcortical evoked potentials compared with physiological changes during the awake-sleep cycle in cats.
Topics: Amphetamine; Anesthetics; Animals; Atropine; Auditory Cortex; Caffeine; Cats; Central Nervous System Stimulants; Cerebral Cortex; Chloralose; Chlorpromazine; Computers; Dihydroxyphenylalanine; Electroencephalography; Evoked Potentials; Hippocampus; Imipramine; Lysergic Acid Diethylamide; Pentobarbital; Perphenazine; Physostigmine; Sleep; Thalamus; Tranquilizing Agents; Visual Cortex; Wakefulness | 1967 |
Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine.
Topics: Amitriptyline; Antidotes; Delirium; Drug Combinations; Female; Humans; Male; Middle Aged; Perphenazine; Physostigmine | 1974 |
Reversal of benztropine toxicity by physostigmine.
Topics: Brain; Chlorpromazine; Female; Humans; Imipramine; Memory, Short-Term; Parasympatholytics; Perphenazine; Physostigmine; Schizophrenia; Thioridazine | 1972 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine Oxidase Inhibitors; Nialamide; Nicotine; Nortropanes; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Physostigmine; Rats; Scopolamine; Sulfonic Acids; Tolazoline; Tremor; Tremorine; Trihexyphenidyl; Tryptamines | 1968 |